Reviews
Review Supports Later-Line Y-90 Radioembolization in Colorectal Liver Metastases
Reddy et alJournal of gastrointestinal cancer

In patients with colorectal liver metastases (CRLM) who are ineligible for surgical resection, systemic chemotherapy offers disease control but infrequently yields durable hepatic responses. Radioembolization utilizing yttrium-90 (Y-90) microspheres, administered intra-arterially to target the predominantly arterial blood supply of hepatic malignancies, serves as a locoregional therapeutic option in this population.
A review of the clinical evidence indicates that patient selection is critical to optimizing therapeutic outcomes. Key evaluation parameters include performance status, hepatic tumor burden, tumor biology, lung shunt fraction, and the presence or extent of extrahepatic disease, with the strongest outcomes reported in patients identified earlier in their disease course. Evidence from randomized controlled trials supports the integration of Y-90 radioembolization into second-line and third-line treatment algorithms; conversely, unselected utilization in the first-line setting has not demonstrated a clinical benefit.
Recent dosimetric advancements, including multicompartment personalized dosing, radiation segmentectomy, and radiation lobectomy, now facilitate ablative intent and bridge-to-resection pathways in carefully selected cohorts. Ongoing and future clinical research aims to emphasize biomarker-driven selection, personalized dosimetry, and rational combinations with systemic regimens to assess whether sustained hepatic disease control yields overall survival gains.
Key Takeaways
- Randomized controlled trials support the use of yttrium-90 radioembolization in second-line and third-line settings for colorectal liver metastases, whereas unselected first-line use has not demonstrated a clinical benefit.
- Multicompartment personalized dosing, radiation segmentectomy, and radiation lobectomy enable ablative and bridge-to-resection strategies in selected patients.
Read the original sourceJournal of gastrointestinal cancer
